background
Combined Treatment of TACE and NK Cell Therapy: A Promising Strategy for Hepatocellular Carcinoma

Combined Treatment of TACE and NK Cell Therapy: A Promising

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths globally, with limited treatment options for advanced-stage disease. Traditionally, locoregional therapies like Transarterial Chemoembolization (TACE) have been used...

Read More
Cellular Immunotherapy becomes boon for Breast Cancer Patient aged 80 years

Cellular Immunotherapy becomes boon for Breast Cancer Patient aged 80

Kamuben Patel, age 80 was diagnosed with breast cancer in July 2023, her condition was already fragile, upset with the current condition her family members were unsure about the way...

Read More